Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is increasingly
used for the treatment of a wide variety of retinal diseases, including age-related macular …

Previous research has implicated vascular endothelial growth factor (VEGF) in the
pathogenesis of diabetic retinopathy (DR). Although many studies reviewed the use of anti …

Anti-vascular endothelial growth factor (anti-VEGF) crunch syndrome describes the
progression to tractional retinal detachment following intravitreal anti-VEGF therapy in an …

Anthocyanins, which are abundant in blueberries, provide significant protection against
many chronic diseases. We investigated the effects of blueberry anthocyanins (BA) on …

Patients struggling with diabetes are at elevated risks for several sight-threatening diseases,
including proliferative diabetic retinopathy (DR). DR manifests in two stages: first, the retinal …

Diabetic retinopathy (DR) is one of the most common complications of diabetes and is a
leading cause of blindness in people of the working age in Western countries. A major …

Diabetic retinopathy (DR) is one of the most common complications of diabetes. This
devastating disease is a leading cause of blindness in people of working age in …

Management of diabetes should involve both systemic and ocular aspects. Control of
hyperglycemia, hypertension and dyslipidemia are of major role in the management of …

Ocular drug delivery systems play a critical role in the treatment of various eye diseases via
ensuring targeted and efficient delivery of therapeutic agent. The complex anatomy and …

Intravitreal injections for the treatment of retinal disorders and intraocular infection have
become a common ophthalmic procedure, and injections of anti-vascular endothelial growth …